Shanghai-Based ProGenTech Draws $21m in VC Funds
Filed in archive Venture Capital on April 2, 2008
ProGenTech, a life science company with offices in Shanghai, Suzhou and Emeryville California, announced last week that it had received US$21 million in venture capital funding from two sources.
According to East Bay Business Times the two funding sources were Bay City Capital of San Francisco and DT Capital of Shanghai.
A press release said that ProGenTech makes "a contamination free, cassette based automated nucleic acid purification systems." I'd probably have to see a picture and take a few biochemistry classes to be able to explain exactly what that means. But the funding is part of a growing trend of venture capital involvement in the medical technologies industry in China.
ProGenTech has been around since 2005 and has about 40 employees.

Tags: ProGenTech Venture capital china venture venture+capital draws+funds based+progentech
Vote for Shanghai-Based ProGenTech Draws $21m in VC Funds:
|
Rating: 6.00 out of 2 vote(s) cast.
|
| RSS | |
|
| |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Follow us on Twitter! |
Most Popular
Agreement
Best of
Blogs
Book review
Commodities
Conferences
Did you know
Entrepreneurship
Incubators and Science Parks
Information Sources
Innovation
Internet
IPOs
Law
M&A
Mergers and Acquisitions
Misc
News
Outsourcing
Policy
